Capital International’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-3,661
Closed -$510K 145
2019
Q2
$510K Hold
3,661
0.12% 119
2019
Q1
$512K Sell
3,661
-24,200
-87% -$3.24M 0.12% 117
2018
Q4
$3.6M Buy
27,861
+26,261
+1,641% +$3.66M 0.97% 31
2018
Q3
$221K Hold
1,600
0.07% 123
2018
Q2
$194K Hold
1,600
0.03% 170
2018
Q1
$205K Hold
1,600
0.04% 167
2017
Q4
$224K Sell
1,600
-125,100
-99% -$17.4M 0.04% 150
2017
Q3
$16.5M Sell
126,700
-5,600
-4% -$742K 1.09% 40
2017
Q2
$17.5M Buy
132,300
+700
+0.5% +$89.3K 1.16% 37
2017
Q1
$16.4M Buy
131,600
+7,900
+6% +$944K 1.07% 38
2016
Q4
$14.3M Buy
123,700
+18,200
+17% +$2.1M 1% 39
2016
Q3
$12.5M Hold
105,500
0.88% 46
2016
Q2
$12.8M Buy
+105,500
New +$12M 0.93% 41

Other funds holding JNJ

Capital International's JNJ Position: Q3 2019 in Review

Capital International sold out of Johnson & Johnson (JNJ) in Q3 2019, closing a stake of 3,661 shares — an estimated $510K sold.

Capital International first reported a position in JNJ in Q2 2016 and held it in 13 quarters. The position peaked at $17.5M in Q2 2017. 2,724 funds tracked by Wall St. Rank hold JNJ as of Q3 2019.

  • Capital International reported no remaining Johnson & Johnson position as of Q3 2019 after selling out during the quarter.
  • Capital International sold 3,661 Johnson & Johnson shares in Q3 2019, an estimated $510K.
  • Capital International first reported a position in Johnson & Johnson in Q2 2016 and held it in 13 quarters.
  • Capital International's Johnson & Johnson position peaked at $17.5M in Q2 2017.
  • 2,724 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2019.

Based on Capital International's 13F filing for Q3 2019, filed 14 Nov 2019.